The Blunt Truth

MAY 15, 2020

Maine made changes to their marijuana program. We reported last week on the DOJ’s memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. This move comes amidst an investigation into the medical marijuana program. SBA funds, however, are not.

Banking 106

Banking Research and Development Programs Advocacy 106

Cannabis Law Report

JULY 20, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

JULY 2, 2019

LegitScript, the global leader in merchant and product certification and monitoring in the e-commerce and payment sectors, has launched a new certification program for legally compliant CBD products and websites. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.

Compliance 40

Compliance Compliance Programs CBD 40

Cannabis Law Report

NOVEMBER 11, 2021

Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs.

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator. ” The spokesperson added, “Those are the sole motivations for the design of the initiative.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

The Cannigma

MAY 16, 2025

The unstable legality of federal protections for medical cannabis, which solely come from an amendment to the DOJ and DEAs budget that has to pass every year, threatens our progress. Thats right there was a federal medical cannabis program way back in 1978. In 1992, however, President Bush Sr. ASA campaigns removed barriers for U.S.

Policy 79

Policy Access Advocacy Patients 79

Cannabis Law Report

JANUARY 14, 2020

Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. Similar to the MORE Act, this bill from Representative Hakeem Jeffries (D-New York) would also remove marijuana and THC from the list of Schedule I drugs and create a grant program for states and local governments “for marijuana conviction expungement programs.”

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

JULY 30, 2021

It also includes comprehensive restorative justice provisions, including grants, loans, and other funding programs for disadvantaged and minority businesses, record expungement, petitions for resentencing, and other measures intended to repair the decades of harm caused by the War on Drugs. Regulatory Oversight of Hemp and Cannabis.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Veriheal

JUNE 23, 2022

Despite the medical cannabis program being implemented in 2018 in Pennsylvania , they remain one of the only states that enforce a zero-tolerance law that also applies to THC metabolites. We can all agree that it is important to address the safety concerns of driving while under the influence of cannabis.

Consumption 105

Consumption Legalization Concentrates Patients 105

Cannabis Law Report

OCTOBER 31, 2019

The illicit extraction operation was detected by OLCC inspectors at an out-of-compliance Oregon Medical Marijuana Program (OMMP) medical grow site. Inspectors from the OLCC OMMP Marijuana Tracking Program were making a proactive check on the Lane County location which had been registered as an OMMP (GSA) grow site.

Oil 45

Oil Extraction Marijuana Hash 45

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. Things have changed a little in the past twenty years, when the DEA gave some researchers permission to study limited amounts of certain psychedelics. POPLAR will publish original law and policy research.

Law 81

Law Research and Development Therapy DEA 81

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

JULY 28, 2022

An Examination of the USDA Hemp Production Program. Hemp Roundtable Vice President and CEO of Kentucky-based Ecofibre, Eric Wang, testified alongside Kentucky Commissioner of Agriculture, Ryan Quarles, during a Congressional hearing regarding “ An Examination of the USDA’s Hemp Production Program.” Washington D.C.

Agriculture 52

Agriculture Hemp CBD Research and Development 52

Cannabis Law Report

JUNE 15, 2021

In addition to eliminating criminal penalties for drug possession at the federal level, the bill also incentivizes state and local governments to adopt decriminalization policies by otherwise limiting their eligibility to receive funds in the Byrne and COPS grant programs. Promotes evidence-based drug education.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Medicinal Genomics

NOVEMBER 12, 2024

As a result, labs that have received a state license to test either medical or recreational cannabis have historically been denied a DEA Schedule I license to test hemp under the 2018 Farm Bill. This must be repeated per batch analyzed by the lab on an ongoing basis as part of the lab’s QAQC program (internal) and state compliance (external).

Compliance 52

Compliance Compliance Data Agriculture 52

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. Will the mandate for the DEA be changed to oversee another special agricultural legal crop or a medicine ?

Legalization 58

Legalization Collective DEA Banking 58

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification.

Marijuana 52

Marijuana Patients Conditions Programs 52

Cannabis Law Report

APRIL 21, 2022

MDMA is a promising psychedelic compound, currently placed by the Drug Enforcement Administration (DEA) in Schedule I of the Controlled Substances Act, that has been produced for legal research in small batches by certified laboratories. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

APRIL 14, 2022

Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52

PrestoDoctor

FEBRUARY 6, 2023

The doctor must be registered with the Oklahoma Medical Marijuana program. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification Additionally, you will need to provide a clear, color, full-face digital photograph. The DEA does not know who has MMJs and no actual database exists.

Marijuana 52

Marijuana Patients Conditions Access 52

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

AUGUST 6, 2021

including building inventory and activating new production capacity along with higher third-party shipping, distribution and warehousing costs, partially offset by payroll subsidies received from the Canadian government in Q1 2022, pursuant to a COVID-19 relief program. Drug Enforcement Administration (the “DEA”), the U.S.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

JULY 14, 2021

The proposed plan would also establish a regulatory framework for state-legal cannabis businesses, expunge non-violent cannabis convictions, and create programs to support small and minority-owned cannabis businesses while reinvesting resources in the communities that have been disproportionately harmed by prohibition. Ron Wyden, D-Ore.,

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

APRIL 13, 2022

market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” Increased client programming with complementary service offerings to be shared and expanded across the combined clinic network.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

MAY 1, 2019

29 The Department of Justice alleged that Google had “allow[ed] online Canadian pharmacies to place advertisements through its AdWords program targeting consumers in the United States” and that Google specifically assisted the pharmacies in “optimizing their AdWords advertisements, and improving the effectiveness of their websites.”

Legalization 45

Legalization Business Law Cannabis 45

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 96

DEA Research and Development Cultivation Supply Chain 96

Meadow

JULY 13, 2018

19:05) What equity programs are currently in place in each of your cities and why are they important to you and your city? (25:28) 25:28) Going beyond equity programs, have there been conversations about creating more diversity in the cannabis industry in your respective cities?

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. What is treatment like through an at-home ketamine program? At-home ketamine treatment programs vary.

Therapy 94

Therapy Access Blood Pressure Treatment 94

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 126

Research and Development DEA Marijuana Pharmaceutical 126

Project CBD

AUGUST 23, 2023

8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .”

Cannabinoids 142

Cannabinoids Hemp THC Safety 142

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas.

Research and Development 81

Research and Development DEA Programs State Laws 81